These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 114872

  • 21. Dopamine- -hydroxylase: regulation of its synthesis and release from nerve terminals.
    Axelrod J.
    Pharmacol Rev; 1972 Jun; 24(2):233-43. PubMed ID: 4344260
    [No Abstract] [Full Text] [Related]

  • 22. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y, Wepierre J, Jacquot C, Rapin J.
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract] [Full Text] [Related]

  • 23. Ultrastructure of thyroid C cells following long-term administration of 1-DOPA or alpha-methyl-DOPA.
    Zabel M.
    Acta Med Pol; 1979 Feb; 20(1):53-4. PubMed ID: 495214
    [No Abstract] [Full Text] [Related]

  • 24. Reduction of aromatic L-amino acid decarboxylase protein in rats after chronic administration of alpha-methyldopa.
    Culvenor AJ, Jarrott B.
    Mol Pharmacol; 1979 Jan; 15(1):86-98. PubMed ID: 106235
    [No Abstract] [Full Text] [Related]

  • 25. Observation on the properties of dopamine-beta-hydroxylase.
    Brown FC, Harralson JD.
    J Neurochem; 1975 Mar; 24(3):467-70. PubMed ID: 1113122
    [No Abstract] [Full Text] [Related]

  • 26. Production of antibodies to rat liver phenylalanine hydroxylase. Cross-reactivity with other pterin-dependent hydroxylases.
    Friedman PA, Lloyd T, Kaufman S.
    Mol Pharmacol; 1972 Sep; 8(5):501-10. PubMed ID: 4404334
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML, Lotti VJ, Clark CM, Stone CA.
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dopamine beta-hydroxylase and tyrosine hydroxylase activities in spontaneously hypertensive rats after NaCl administration.
    Nagatsu T, Kato T, Numata Y, Ikuta K, Kuzuya H.
    Experientia; 1975 Jul 15; 31(7):767-8. PubMed ID: 237779
    [No Abstract] [Full Text] [Related]

  • 30. Changes in vesicular dopamine-beta-hydroxylase resulting from transmitter release.
    Fillenz M, West DP.
    J Neurochem; 1974 Aug 15; 23(2):411-6. PubMed ID: 4420583
    [No Abstract] [Full Text] [Related]

  • 31. Effect of hypophysectomy on adrenal dopamine -hydroxylase activity in the rat.
    Gewirtz GP, Kvetnanský R, Weise VK, Kopin IJ.
    Mol Pharmacol; 1971 Mar 15; 7(2):163-8. PubMed ID: 4331155
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dopamine- -hydroxylase inhibition by dimethyldithiocarbamate and related compounds.
    Lippmann W, Lloyd K.
    Biochem Pharmacol; 1969 Oct 15; 18(10):2507-16. PubMed ID: 5403987
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tyrosine hydroxylase in human adrenal glands and human pheochromocytoma.
    Nagatsu T, Mizutani K, Sudo Y, Nagatsu I.
    Clin Chim Acta; 1972 Jul 15; 39(2):417-24. PubMed ID: 4402930
    [No Abstract] [Full Text] [Related]

  • 40. [Effect of catapresan, alpha-methyldopa and L-DOPA on segmental mechanisms of vasomotor regulation].
    Zaĭtsev AA.
    Farmakol Toksikol; 1978 Jul 15; 41(6):690-3. PubMed ID: 720580
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.